These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21889605)

  • 1. Where do innovative drugs come from?
    Higgs G
    Drug Discov Today; 2011 Nov; 16(21-22):907-9. PubMed ID: 21889605
    [No Abstract]   [Full Text] [Related]  

  • 2. Wrong questions, wrong answers? Are we getting the drugs we need?
    Lipworth WL; Kerridge IH; Day RO
    Clin Pharmacol Ther; 2012 Mar; 91(3):367-9. PubMed ID: 22343808
    [No Abstract]   [Full Text] [Related]  

  • 3. Learning lessons from drugs that have recently entered the market.
    Teague SJ
    Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can biochemistry drive drug discovery beyond simple potency measurements?
    Chène P
    Drug Discov Today; 2012 Apr; 17(7-8):388-95. PubMed ID: 22326379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous flow synthesis. A pharma perspective.
    Malet-Sanz L; Susanne F
    J Med Chem; 2012 May; 55(9):4062-98. PubMed ID: 22283413
    [No Abstract]   [Full Text] [Related]  

  • 8. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
    Betz UA
    Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could pharma open its drug freezers?
    Mullard A
    Nat Rev Drug Discov; 2011 Jun; 10(6):399-400. PubMed ID: 21629278
    [No Abstract]   [Full Text] [Related]  

  • 10. [The discovery process in the pharmaceutical industry].
    Scatton B
    J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizing for innovation: towards successful translational research.
    West W; Nightingale P
    Trends Biotechnol; 2009 Oct; 27(10):558-61. PubMed ID: 19683820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What makes a good drug target?
    Gashaw I; Ellinghaus P; Sommer A; Asadullah K
    Drug Discov Today; 2011 Dec; 16(23-24):1037-43. PubMed ID: 21945861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment screening to predict druggability (ligandability) and lead discovery success.
    Edfeldt FN; Folmer RH; Breeze AL
    Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179
    [No Abstract]   [Full Text] [Related]  

  • 15. Between confidentiality and scientific exchange: the place of publication in drug discovery and pharmaceutical research.
    Clozel M
    Sci Transl Med; 2011 Jan; 3(67):67cm2. PubMed ID: 21270337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22666880
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural products as catalysts for innovation: a pharmaceutical industry perspective.
    Schmitt EK; Moore CM; Krastel P; Petersen F
    Curr Opin Chem Biol; 2011 Aug; 15(4):497-504. PubMed ID: 21684800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility index as a practical multiattribute approach to drug development decisions.
    Poland B; Hodge FL; Khan A; Clemen RT; Wagner JA; Dykstra K; Krishna R
    Clin Pharmacol Ther; 2009 Jul; 86(1):105-8. PubMed ID: 19458614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
    Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
    Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.